Due to health issues, this site is no longer maintained and will be shut down shortly. |
Can Fite Biofarma Ltd is a clinical stage biopharmaceutical company. It develops orally bioavailable small molecule therapeutic products for the treatment of autoimmune-inflammatory, oncological and ophthalmic diseases. This is an ADR of a company whose stock trades outside of the U.S. as the symbol IT:CFBI.
$2.19 0.00 (0.00%)
As of 03/27/2023 11:01:18 EST IEX book CBOE book
2022 © Stock Market MBA, Inc.